Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 405

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 405
---
 the period for income taxes
     
    $
    22,587

    $
    15,081

    $
    1,695

    Supplemental schedule of non-cash activities:

    Common stock issued for conversion or exchange of 2024 Notes
     
    $
    105,757

    $
    693,377

    $
    —

    Intangible assets and property and equipment included in accounts payable and accrued expenses
     
    $
    42,740

    $
    33,339

    $
    6,765

    Lease liabilities arising from obtaining right of use assets
     
    $
    35,361

    $
    80,203

    $
    40,006

    Capitalized stock-based compensation and depreciation as inventory
     
    $
    28,549

    $
    —

    $
    —

    Lease liabilities terminated
     
    $
    2,381

    $
    —

    $
    3,807

See accompanying notes to consolidated financial statements.

F-7

Sarepta Therapeutics, Inc.